📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Circulating tumour DNA is a potential biomarker for disease progression and response to targeted therapy in advanced thyroid cancer. (2018)

First Author: Allin DM

Attributed to: MICA: Using circulating tumour DNA to identify and predict mechanisms of resistance to targeted cancer therapies. funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.ejca.2018.08.013

PubMed Identifier: 30253333

Publication URI: http://europepmc.org/abstract/MED/30253333

Type: Journal Article/Review

Volume: 103

Parent Publication: European journal of cancer (Oxford, England : 1990)

ISSN: 0959-8049